Welcome to our dedicated page for Acacia Resh SEC filings (Ticker: ACTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Acacia Research's SEC filings reveal how this patent licensing company generates revenue across its intellectual property portfolio and operating businesses. The 10-K annual report breaks down licensing revenue by technology category and discloses the status of major patent enforcement campaigns, showing which sectors drive monetization success.
For a company with variable quarterly results, the 10-Q reports matter. Patent licensing revenue can swing dramatically based on settlement timing, making sequential comparisons essential for understanding business momentum. These quarterly filings also detail legal expenses, which directly affect profitability in the patent assertion business.
Form 4 insider transactions show when executives and directors buy or sell ACTG shares. Given the inherent unpredictability of patent licensing outcomes, tracking insider activity provides additional context for investment decisions. Our AI highlights these transactions as they're filed, so you don't miss patterns in insider behavior.
The 8-K filings capture material events as they happen: significant licensing agreements, litigation outcomes, and business acquisitions. For Acacia Research, these event-driven filings often contain the most market-moving information. Proxy statements (DEF 14A) reveal executive compensation structures, important for understanding how management incentives align with shareholder interests in this specialized business model.
Our AI-powered summaries explain what each filing means for ACTG shareholders, translating legal and accounting terminology into actionable insights without requiring hours of document analysis.
Acacia Research (ACTG) reported Q3 results showing higher revenue and narrower losses while integrating recent acquisitions across energy, industrial, and manufacturing operations.
Total revenue was $59.4 million, up from $23.3 million a year ago, led by manufacturing ($30.8 million) from the Deflecto business and stronger intellectual property licensing ($7.8 million, driven by paid-up licenses). Energy contributed $14.2 million and industrial $6.7 million. Operating loss improved to $6.4 million from $10.3 million, and net loss attributable to Acacia narrowed to $2.7 million, or $0.03 per share, from $14.0 million, or $0.14 per share.
For the nine months, revenue reached $235.1 million versus $73.5 million, with operating income of $19.5 million and net income of $18.3 million. Cash and cash equivalents were $301.8 million as of September 30, 2025. Benchmark’s revolving credit facility balance was $58.5 million and the Deflecto facility was $35.5 million. Shares outstanding were 96,460,378 as of September 30, 2025.
Acacia Research Corporation furnished a press release announcing its financial results for the quarter ended September 30, 2025. The release was provided under Item 2.02 and is attached as Exhibit 99.1. The company notes this information is being furnished and is not deemed “filed” under Section 18 of the Exchange Act, and it will not be incorporated by reference into Securities Act filings unless specifically referenced.
Exhibits include: 99.1 (Press Release dated November 5, 2025) and 104 (Cover Page Interactive Data File).
Gavin T. Molinelli, a director of Acacia Research Corp (ACTG), received 9,231 shares of the company's common stock on 09/30/2025 as payment in lieu of cash for director fees for Q3 2025. The shares were issued at a price of $3.25 per share. After the grant, Mr. Molinelli beneficially owned 160,218 shares of Acacia Research Corp.
The Form 4 was signed by Mr. Molinelli on 10/01/2025 and reports a routine, non-derivative acquisition of equity tied to director compensation. The filing shows direct ownership and does not report any derivative transactions.
Zambito Michael SIKORYAK, identified on the filing as the issuer's Chief Financial Officer, reported a purchase of 7,700 shares of Acacia Research Corporation (ACTG) on 08/11/2025. The transaction was coded P for a purchase and was executed at a weighted average price of $3.2658, with the filing noting component trades priced between $3.25 and $3.32. Following the transaction the reporting person beneficially owned 7,700 shares in a direct capacity.
The Form 4 was signed by an attorney-in-fact, Jennifer Graff, on 08/12/2025. No derivative transactions or other securities classes are reported on this filing, and no amendments or additional material items are included.
Michelle Felman, identified as a director of Acacia Research Corporation (ACTG), reported two gift transactions of company common stock dated 08/11/2025. The filing states she gifted 11,560 shares and 11,561 shares to an irrevocable trust established for the benefit of her son, and that each gift was for no consideration.
The Form 4 shows the transactions coded as gifts and reports post-transaction direct beneficial ownership figures of 43,733 shares and 32,172 shares respectively as listed on the form. The filing is signed by an attorney-in-fact.
FAQ
What is the current stock price of Acacia Resh (ACTG)?
What is the market cap of Acacia Resh (ACTG)?
